Mirae Asset Global Investments Co. Ltd. Has $1.46 Million Position in InterCure Ltd. (NASDAQ:INCR)

Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of InterCure Ltd. (NASDAQ:INCRFree Report) by 31.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,140,977 shares of the company’s stock after acquiring an additional 271,080 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in InterCure were worth $1,460,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. Balyasny Asset Management LLC acquired a new stake in shares of InterCure during the 3rd quarter valued at about $233,000. Renaissance Technologies LLC acquired a new position in InterCure in the first quarter valued at about $91,000. Citadel Advisors LLC boosted its position in InterCure by 70.4% in the second quarter. Citadel Advisors LLC now owns 25,661 shares of the company’s stock valued at $149,000 after buying an additional 10,598 shares in the last quarter. BlackRock Inc. acquired a new position in InterCure in the third quarter valued at about $58,000. Finally, UBS Group AG boosted its position in InterCure by 222.3% in the third quarter. UBS Group AG now owns 6,337 shares of the company’s stock valued at $29,000 after buying an additional 4,371 shares in the last quarter. 8.34% of the stock is currently owned by institutional investors and hedge funds.

InterCure Stock Down 2.3 %

NASDAQ:INCR opened at $2.53 on Monday. The firm has a market cap of $115.29 million, a PE ratio of 19.46 and a beta of 1.73. InterCure Ltd. has a 12 month low of $0.99 and a 12 month high of $2.92. The company’s 50-day moving average price is $2.17 and its two-hundred day moving average price is $1.58.

InterCure Profile

(Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Featured Articles

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCRFree Report).

Institutional Ownership by Quarter for InterCure (NASDAQ:INCR)

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.